CASP8 D302H and meningioma risk: An analysis of five case-control series

Cancer Letters

Volumn 273, Issue 2, 2009, Pages 312-315

  Bethke, Lara ^a   Sullivan, Kate ^a   Webb, Emily ^a   Murray, Anne ^a   Schoemaker, Minouk ^a   Auvinen, Anssi ^b,c   Kiuru, Anne ^b   Salminen, Tiina ^b,c   Johansen, Christoffer ^d   Christensen, Helle Collatz ^d   Muir, Kenneth ^e   McKinney, Patricia ^f   Hepworth, Sarah ^f   Dimitropoulou, Polyxeni ^e   Lophatananon, Artitaya ^e   Feychting, Maria ^g   Lönn, Stefan ^g   Ahlbom, Anders ^g   Malmer, Beatrice ^h   Henriksson, Roger ^h   Swerdlow, Anthony ^a   Houlston, Richard ^a   more..

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF TAMPERE   (Finland)

^c STUK RADIATION AND NUCLEAR SAFETY AUTHORITY   (Finland)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^f Centre for Epidemiology and Biostatistics   (United Kingdom)

^g KAROLINSKA INSTITUTE   (Sweden)

^h UMEÅ UNIVERSITY   (Sweden)

Author keywords

Caspase 8; Meningioma; Polymorphism; Risk

Indexed keywords

CASPASE 8;

ADULT; APOPTOSIS; ARTICLE; CANCER PATIENT; CANCER RISK; CASP8 GENE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; ONCOGENE; PRIORITY JOURNAL;

ADULT; AGED; ALLELES; APOPTOSIS; CASE-CONTROL STUDIES; CASPASE 8; FEMALE; GENETIC VARIATION; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK;

EID: 57349105754     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.08.010     Document Type: Article

References (16)

1. Louis D.N., Scheithauer B.W., Budka H., von Deimling A., and Kepes J.J. Meningiomas. In: Kleihues P., and Cavenee W.K. (Eds). Pathology and Genetics. Tumours of the Nervous System, WHO Classification of Tumors (2000), IARC Press, Lyon 176-184
2. D'Alessandro G., Di Giovanni M., Iannizzi L., Guidetti E., and Bottacchi E. Epidemiology of primary intracranial tumors in the Valle d'Aosta (Italy) during the 6-year period 1986-1991. Neuroepidemiology 14 (1995) 139-146
3. Bauchet L., Rigau V., Mathieu-Daude H., Figarella-Branger D., Hugues D., Palusseau L., Bauchet F., Fabbro M., Campello C., Capelle L., Durand A., Tretarre B., Frappaz D., Henin D., Menei P., Honnorat J., and Segnarbieux F. French brain tumor data bank: methodology and first results on 10,000 cases. J. Neurooncol. 84 (2007) 189-199
4. Kuratsu J., Takeshima H., and Ushio Y. Trends in the incidence of primary intracranial tumors in Kumamoto, Japan. Int. J. Clin. Oncol. 6 (2001) 183-191
5. Hodgson S., and Maher E. A Practical Guide to Human Cancer Genetics. second ed. (1999), Cambridge University Press, Cambridge, England pp. 37-38
6. Hemminki K., and Li X. Familial risks in nervous system tumors. Cancer Epidemiol. Biomarkers Prev. 12 (2003) 1137-1142
7. Custer B.S., Koepsell T.D., and Mueller B.A. The association between breast carcinoma and meningioma in women. Cancer 94 (2002) 1626-1635
8. Cox A., Dunning A.M., Garcia-Closas M., Balasubramanian S., Reed M.W., Pooley K.A., Scollen S., Baynes C., Ponder B.A., Chanock S., Lissowska J., Brinton L., Peplonska B., Southey M.C., Hopper J.L., McCredie M.R., Giles G.G., Fletcher O., Johnson N., dos Santos Silva I., Gibson L., Bojesen S.E., Nordestgaard B.G., Axelsson C.K., Torres D., Hamann U., Justenhoven C., Brauch H., Chang-Claude J., Kropp S., Risch A., Wang-Gohrke S., Schurmann P., Bogdanova N., Dork T., Fagerholm R., Aaltonen K., Blomqvist C., Nevanlinna H., Seal S., Renwick A., Stratton M.R., Rahman N., Sangrajrang S., Hughes D., Odefrey F., Brennan P., Spurdle A.B., Chenevix-Trench G., Beesley J., Mannermaa A., Hartikainen J., Kataja V., Kosma V.M., Couch F.J., Olson J.E., Goode E.L., Broeks A., Schmidt M.K., Hogervorst F.B., Van't Veer L.J., Kang D., Yoo K.Y., Noh D.Y., Ahn S.H., Wedren S., Hall P., Low Y.L., Liu J., Milne R.L., Ribas G., Gonzalez-Neira A., Benitez J., Sigurdson A.J., Stredrick D.L., Alexander B.H., Struewing J.P., Pharoah P.D., and Easton D.F. A common coding variant in CASP8 is associated with breast cancer risk. Nat. Genet. 39 (2007) 352-358
9. Bethke L., Sullivan K., Webb E., Murray A., Schoemaker M., Auvinen A., Kiuru A., Salminen T., Johansen C., Christensen H.C., Muir K., McKinney P., Hepworth S., Dimitropoulou P., Lophatananon A., Feychting M., Lonn S., Ahlbom A., Malmer B., Henriksson R., Swerdlow A., and Houlston R. The common D302H variant of CASP8 is associated with risk of glioma. Cancer Epidemiol. Biomarkers Prev. 17 (2008) 987-989
10. Cardis E., Richardson L., Deltour I., Armstrong B., Feychting M., Johansen C., Kilkenny M., McKinney P., Modan B., Sadetzki S., Schuz J., Swerdlow A., Vrijheid M., Auvinen A., Berg G., Blettner M., Bowman J., Brown J., Chetrit A., Christensen H.C., Cook A., Hepworth S., Giles G., Hours M., Iavarone I., Jarus-Hakak A., Klaeboe L., Krewski D., Lagorio S., Lonn S., Mann S., McBride M., Muir K., Nadon L., Parent M.E., Pearce N., Salminen T., Schoemaker M., Schlehofer B., Siemiatycki J., Taki M., Takebayashi T., Tynes T., van Tongeren M., Vecchia P., Wiart J., Woodward A., and Yamaguchi N. The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur. J. Epidemiol. 22 (2007) 647-664
11. Petitti D. Meta-analysis Decision Analysis and Cost-effectiveness Analysis (1994), Oxford, New York, Oxford
12. Rajaraman P., Wang S.S., Rothman N., Brown M.M., Black P.M., Fine H.A., Loeffler J.S., Selker R.G., Shapiro W.R., Chanock S.J., and Inskip P.D. Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 1655-1661
13. Sun T., Gao Y., Tan W., Ma S., Shi Y., Yao J., Guo Y., Yang M., Zhang X., Zhang Q., Zeng C., and Lin D. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat. Genet. 39 (2007) 605-613
14. Haiman C.A., Garcia R.R., Kolonel L.N., Henderson B.E., Wu A.H., and Le Marchand L. A promoter polymorphism in the CASP8 gene is not associated with cancer risk. Nat. Genet. 40 (2008) 259-260 (Author reply 260-1)
15. Pittman A.M., Broderick P., Sullivan K., Fielding S., Webb E., Penegar S., Tomlinson I., and Houlston R.S. CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population. Br. J. Cancer 98 (2008) 1434-1436
16. Frank B., Rigas S.H., Bermejo J.L., Wiestler M., Wagner K., Hemminki K., Reed M.W., Sutter C., Wappenschmidt B., Balasubramanian S.P., Meindl A., Kiechle M., Bugert P., Schmutzler R.K., Bartram C.R., Justenhoven C., Ko Y.D., Bruning T., Brauch H., Hamann U., Pharoah P.P., Dunning A.M., Pooley K.A., Easton D.F., Cox A., and Burwinkel B. The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study. Breast Cancer Res. Treat. 111 (2008) 139-144